![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
On July 5, at the first "China's TCM Prevention and Treatment of Viral Infectious Diseases" summit forum, the "China Federation of Chinese Medicine Prevention and Control of Viral Infectious Diseases, Production and Research" led by Zhong Nanshan, Li Lianda, Liu Changxiao, Li Lanjuan, Yao Xinsheng and other five academicians. Officially established. It is reported that this is the first cross-domain production-study-research association created by the Chinese medicine community in China, and it is also a brand-new attempt by China's Chinese medicine community to integrate existing resources to overcome scientific research problems.
According to reports, over the past 30 years, China’s modernization of traditional Chinese medicine has basically formed two major scientific research forces represented by scientific research institutes and self-built research institutions of enterprises, but this also brings inevitable limitations, corporate needs and the The problem is difficult to effectively dock, thereby affecting the efficiency of industrialization of science and technology. For this reason, some Chinese medicine companies are actively exploring in recent years, such as setting up joint laboratories with colleges and universities and research institutes, co-building key laboratories, and so on.
It is reported that given that for a long period of time to cure the global infectious diseases such as influenza, bird flu, hand, foot and mouth disease and even hepatitis B, the alliance will focus on research on antiviral mechanisms of Chinese medicine. The first batch of key research products will focus on products such as Stomatitis and Radix isatidis.
In order to further promote the progress of the entire alliance, the first batch of 20 million yuan research fund for the production, research, and development of TCM medicines provided by Baiyun Mountain and Huanghua Medicine was officially launched. Li Chuyuan said that this is only the first batch of funds, and the next step will be to apply for funds from Li Ka Shing Foundation and other channels to apply for funding. The initial application target is 100 million yuan.
According to reports, over the past 30 years, China’s modernization of traditional Chinese medicine has basically formed two major scientific research forces represented by scientific research institutes and self-built research institutions of enterprises, but this also brings inevitable limitations, corporate needs and the The problem is difficult to effectively dock, thereby affecting the efficiency of industrialization of science and technology. For this reason, some Chinese medicine companies are actively exploring in recent years, such as setting up joint laboratories with colleges and universities and research institutes, co-building key laboratories, and so on.
It is reported that given that for a long period of time to cure the global infectious diseases such as influenza, bird flu, hand, foot and mouth disease and even hepatitis B, the alliance will focus on research on antiviral mechanisms of Chinese medicine. The first batch of key research products will focus on products such as Stomatitis and Radix isatidis.
In order to further promote the progress of the entire alliance, the first batch of 20 million yuan research fund for the production, research, and development of TCM medicines provided by Baiyun Mountain and Huanghua Medicine was officially launched. Li Chuyuan said that this is only the first batch of funds, and the next step will be to apply for funds from Li Ka Shing Foundation and other channels to apply for funding. The initial application target is 100 million yuan.